Disclosures Markus A. Rose has received research funding and speaker's fees from Wyeth/Pfizer, Germany.
The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe
Article first published online: 19 JUL 2013
© 2013 The Authors. International Journal of Clinical Practice published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
International Journal of Clinical Practice
Volume 68, Issue 1, pages 8–19, January 2014
How to Cite
Rose, M. A., Christopoulou, D., Myint, T. T. H. and de Schutter, I. (2014), The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe. International Journal of Clinical Practice, 68: 8–19. doi: 10.1111/ijcp.12234
Dina Christopoulou is an employee of Pfizer Ltd, UK.
Tin Tin Htar Myint is an employee of Pfizer Pharmaceuticals, France.
Iris de Schutter has been an invited speaker for Pfizer and has participated in advisory boards for GlaxoSmithKline Biologicals and Pfizer in the past 3 years.
Linked Comment: Stein. Int J Clin Pract 2014; 68: 2–3.
- Issue published online: 17 DEC 2013
- Article first published online: 19 JUL 2013
- Manuscript Accepted: 19 JUN 2013
- Manuscript Received: 1 MAR 2013
Table S1. Incidence of IPD in children from a) indigenous populations; and b) non-white ethnic groups
Table S2. Risk of IPD in indigenous populations and non-white ethnic groups
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.